AQST 8-K 2026-09-29

Aquestive Therapeutics, Inc. (AQST) 8-K dated 2026-09-29 — accession 0001398733-26-000052. This URL is the filing, not the AQST hub.

Aquestive Therapeutics, Inc. (AQST) is a drug manufacturers - specialty & generic company listed on US.

Aquestive Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001398733-26-000052.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AQST revenue for 2025-12-31 was $44.5M. Net income was -$83.8M. Revenue was down 22.6% from 2024-12-31 to 2025-12-31. AQST currently screens at market cap $493.0M.

Not investment advice. The AQST SEC hub lists recent forms. The stock page is the research view.